The Cancer Genome Atlas (TCGA) consortium identified six somatic mutations in glioblastomas that affect EGFR protein structure, ranging from extracellular domain point mutations and deletions to deletions in the cytoplasmic tail of the receptor [24]. Here, EGFR is linked to glioblastoma.